The current stock price of QIPT is 3.59 USD. In the past month the price increased by 1.7%. In the past year, price increased by 11.15%.
ChartMill assigns a technical rating of 9 / 10 to QIPT. When comparing the yearly performance of all stocks, QIPT is one of the better performing stocks in the market, outperforming 87.23% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to QIPT. QIPT has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months QIPT reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS decreased by -108.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.78% | ||
| ROE | -10.66% | ||
| Debt/Equity | 0.95 |
11 analysts have analysed QIPT and the average price target is 3.93 USD. This implies a price increase of 9.47% is expected in the next year compared to the current price of 3.59.
For the next year, analysts expect an EPS growth of 28.6% and a revenue growth 27.89% for QIPT
Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. The company is headquartered in Wilder, Kentucky. The company went IPO on 2014-03-18. The firm's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The firm's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. The company has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.
QUIPT HOME MEDICAL CORP
1019 Town Drive
Wilder KENTUCKY US
CEO: Gregory Crawford
Employees: 1200
Phone: 18598782220
Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. The company is headquartered in Wilder, Kentucky. The company went IPO on 2014-03-18. The firm's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The firm's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. The company has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.
The current stock price of QIPT is 3.59 USD. The price increased by 0.28% in the last trading session.
QIPT does not pay a dividend.
QIPT has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
11 analysts have analysed QIPT and the average price target is 3.93 USD. This implies a price increase of 9.47% is expected in the next year compared to the current price of 3.59.
QUIPT HOME MEDICAL CORP (QIPT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).
The outstanding short interest for QUIPT HOME MEDICAL CORP (QIPT) is 1.93% of its float.